REGENXBIO Inc. (RGNX)


REGENXBIO Inc. (RGNX)

$33.93 USD

1.14 (-3.25%)

Updated Aug 23 12:00am

Add RGNX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 329 in Biotech

See all “A” rated Strong Buy stocks

RGNX Daily Price Range
RGNX 52-Week Price Range

RGNX Stock Chart More Charts


RGNX Price/Volume Stats

Current price $33.93
Prev. close $35.07
Day low $33.73
Day high $36.02
50-day MA $45.29
200-day MA $49.60
52-week high $83.45
52-week low $33.73
Volume 422,800
Avg. volume 554,753
Dividend yield N/A
Market Cap 1.25B

REGENXBIO Inc. (RGNX) Company Bio


REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company was founded in 2009 and is based in Rockville, Maryland.





RGNX News Stream


Event/Time News Detail
Loading, please wait...

RGNX Social Stream


Loading social stream, please wait...

View Full RGNX Social Stream

RGNX Returns

1-mo -31.77%
3-mo -30.64%
6-mo -36.27%
1-year -48.71%
3-year 172.75%
5-year N/A
YTD -19.12%
2018 26.17%
2017 79.25%
2016 11.75%
2015 N/A
2014 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4334 seconds.